{
  "docId": "019dd923-622c-750b-8b9b-7e7228555e88",
  "docSlug": "36c903ba19aa",
  "documentTitle": "Allergan, Inc. (AGN)",
  "authorId": "01_Pershing_Square",
  "authorName": "William Ackman",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2014-04-22 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.70665085,
  "pageNumber": 87,
  "pageCount": 110,
  "prevPage": 86,
  "nextPage": 88,
  "slideType": "other",
  "function": "establish_context",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "This slide serves as a historical context piece for an activist investor's thesis regarding a specific executive's track record.",
  "elementsJson": [
    "headline_text",
    "subtitle_text",
    "bullet_list",
    "footnote"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/87",
  "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-87",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.82,
        "x": 0.09,
        "y": 0.13
      },
      "kind": "callout",
      "text": "Platform Specialty Products (NYSE: PAH)",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "861bc568-5707-4835-b422-3c96ff24aa3d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.82,
        "x": 0.09,
        "y": 0.19
      },
      "kind": "list",
      "text": "Martin Franklin, Chairman of Jarden, co-founded PAH in 2013\nIn May 2013, PAH raised ~$881mm and began trading at a valuation close to this cash balance\nPershing Square invested $250mm in PAH and owns 27% of the company\nIn October 2013, PAH announced the acquisition of MacDermid Inc., for $1.8bn cash and equity, a specialty chemical company with significant platform potential",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "10fbe820-d924-44ca-8e60-54b050b010c1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.09,
        "y": 0.48
      },
      "kind": "source-note",
      "text": "(1) http://ir.platformspecialtyproducts.com/faq.cfm\n(2) TR-1 Notification of Major Interest in Shares filed May 29, 2013 and Pershing Square investment information.\n(3) Ownership calculated based on PAH shares outstanding as of April 10, 2014.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a930931-f7cd-44f9-ac1c-da39ef23b1fd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.09,
        "y": 0.09
      },
      "kind": "title",
      "text": "Martin Franklin's Next Platform",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c63fbda-aeaf-49c4-9e38-241c8bc1fd9d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}